New hope for pancreatic cancer: study tests Cutting-Edge therapies
NCT ID NCT04481204
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study aimed to test new treatments for people with pancreatic cancer that hasn't spread. It was designed for three groups: those whose tumors can be removed by surgery, those where it's borderline, and those with advanced local disease. The goal was to see if new therapies work better than standard chemotherapy. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.